메뉴 건너뛰기




Volumn 8, Issue 4, 2013, Pages

Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; CD28 ANTIGEN; CYTOKINE; PROTEIN BCL 2; SURVIVIN; T LYMPHOCYTE RECEPTOR; URELUMAB;

EID: 84875663346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060031     Document Type: Article
Times cited : (120)

References (35)
  • 1
    • 77951714425 scopus 로고    scopus 로고
    • Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients
    • Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, et al. (2010) Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res 16(9): 2646-55.
    • (2010) Clin Cancer Res , vol.16 , Issue.9 , pp. 2646-2655
    • Besser, M.J.1    Shapira-Frommer, R.2    Treves, A.J.3    Zippel, D.4    Itzhaki, O.5
  • 2
    • 0037174674 scopus 로고    scopus 로고
    • Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
    • Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594): 850-4.
    • (2002) Science , vol.298 , Issue.5594 , pp. 850-854
    • Dudley, M.E.1    Wunderlich, J.R.2    Robbins, P.F.3    Yang, J.C.4    Hwu, P.5
  • 3
    • 84871207055 scopus 로고    scopus 로고
    • Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients
    • Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, et al. (2012) Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24): 6758-70.
    • (2012) Clin Cancer Res , vol.18 , Issue.24 , pp. 6758-6770
    • Radvanyi, L.G.1    Bernatchez, C.2    Zhang, M.3    Fox, P.S.4    Miller, P.5
  • 4
    • 79960299888 scopus 로고    scopus 로고
    • Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
    • Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, et al. (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17(13): 4550-7.
    • (2011) Clin Cancer Res , vol.17 , Issue.13 , pp. 4550-4557
    • Rosenberg, S.A.1    Yang, J.C.2    Sherry, R.M.3    Kammula, U.S.4    Hughes, M.S.5
  • 5
    • 84855952269 scopus 로고    scopus 로고
    • Targeting metastatic melanoma
    • Flaherty KT, (2011) Targeting metastatic melanoma. Annu Rev Med 63: 171-83.
    • (2011) Annu Rev Med , vol.63 , pp. 171-183
    • Flaherty, K.T.1
  • 6
    • 84858758766 scopus 로고    scopus 로고
    • Adoptive immunotherapy for cancer: harnessing the T cell response
    • Restifo NP, Dudley ME, Rosenberg SA, (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4): 269-81.
    • (2012) Nat Rev Immunol , vol.12 , Issue.4 , pp. 269-281
    • Restifo, N.P.1    Dudley, M.E.2    Rosenberg, S.A.3
  • 7
    • 84859471907 scopus 로고    scopus 로고
    • Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook
    • Wu R, Forget MA, Chacon J, Bernatchez C, Haymaker C, et al. (2012) Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J 18(2): 160-75.
    • (2012) Cancer J , vol.18 , Issue.2 , pp. 160-175
    • Wu, R.1    Forget, M.A.2    Chacon, J.3    Bernatchez, C.4    Haymaker, C.5
  • 8
    • 73949086540 scopus 로고    scopus 로고
    • MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
    • Li Y, Liu S, Hernandez J, Vence L, Hwu P, et al. (2010) MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro. J Immunol 184(1): 452-65.
    • (2010) J Immunol , vol.184 , Issue.1 , pp. 452-465
    • Li, Y.1    Liu, S.2    Hernandez, J.3    Vence, L.4    Hwu, P.5
  • 9
    • 11144241310 scopus 로고    scopus 로고
    • Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
    • Powell DJ Jr, Dudley ME, Robbins PF, Rosenberg SA, (2005) Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105(1): 241-50.
    • (2005) Blood , vol.105 , Issue.1 , pp. 241-250
    • Powell Jr, D.J.1    Dudley, M.E.2    Robbins, P.F.3    Rosenberg, S.A.4
  • 10
    • 67449092903 scopus 로고    scopus 로고
    • Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients
    • Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, et al. (2009) Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. J Immunother 32(4): 415-23.
    • (2009) J Immunother , vol.32 , Issue.4 , pp. 415-423
    • Besser, M.J.1    Shapira-Frommer, R.2    Treves, A.J.3    Zippel, D.4    Itzhaki, O.5
  • 11
    • 11344251911 scopus 로고    scopus 로고
    • Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
    • Zhou J, Dudley ME, Rosenberg SA, Robbins PF, (2005) Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother 28(1): 53-62.
    • (2005) J Immunother , vol.28 , Issue.1 , pp. 53-62
    • Zhou, J.1    Dudley, M.E.2    Rosenberg, S.A.3    Robbins, P.F.4
  • 12
    • 27744450650 scopus 로고    scopus 로고
    • Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
    • Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, et al. (2005) Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 175(10): 7046-52.
    • (2005) J Immunol , vol.175 , Issue.10 , pp. 7046-7052
    • Zhou, J.1    Shen, X.2    Huang, J.3    Hodes, R.J.4    Rosenberg, S.A.5
  • 13
    • 0037829421 scopus 로고    scopus 로고
    • Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
    • Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA, (2003) Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 26(4): 332-42.
    • (2003) J Immunother , vol.26 , Issue.4 , pp. 332-342
    • Dudley, M.E.1    Wunderlich, J.R.2    Shelton, T.E.3    Even, J.4    Rosenberg, S.A.5
  • 14
    • 79953041310 scopus 로고    scopus 로고
    • Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function
    • Hernandez-Chacon JA, Li Y, Wu RC, Bernatchez C, Wang Y, et al. (2011) Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function. J Immunother 34(3): 236-50.
    • (2011) J Immunother , vol.34 , Issue.3 , pp. 236-250
    • Hernandez-Chacon, J.A.1    Li, Y.2    Wu, R.C.3    Bernatchez, C.4    Wang, Y.5
  • 15
    • 62549160588 scopus 로고    scopus 로고
    • First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting
    • Molckovsky A Siu LL, (2008) First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting. J Hematol Oncol 1: 20.
    • (2008) J Hematol Oncol , vol.1 , pp. 20
    • Molckovsky, A.1    Siu, L.L.2
  • 16
    • 24344469675 scopus 로고    scopus 로고
    • A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells
    • He L, Hakimi J, Salha D, Miron I, Dunn P, et al. (2005) A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells. J Immunol Methods 304(1-2): 43-59.
    • (2005) J Immunol Methods , vol.304 , Issue.1-2 , pp. 43-59
    • He, L.1    Hakimi, J.2    Salha, D.3    Miron, I.4    Dunn, P.5
  • 17
    • 17644389199 scopus 로고    scopus 로고
    • TNF/TNFR family members in costimulation of T cell responses
    • Watts TH, (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
    • (2005) Annu Rev Immunol , vol.23 , pp. 23-68
    • Watts, T.H.1
  • 18
    • 74549216531 scopus 로고    scopus 로고
    • Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells
    • Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010) Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32(1): 79-90.
    • (2010) Immunity , vol.32 , Issue.1 , pp. 79-90
    • Pipkin, M.E.1    Sacks, J.A.2    Cruz-Guilloty, F.3    Lichtenheld, M.G.4    Bevan, M.J.5
  • 19
    • 78651272579 scopus 로고    scopus 로고
    • Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes
    • Parish ST, Wu JE, Effros RB, (2010) Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol 30(6): 798-805.
    • (2010) J Clin Immunol , vol.30 , Issue.6 , pp. 798-805
    • Parish, S.T.1    Wu, J.E.2    Effros, R.B.3
  • 20
    • 19344374856 scopus 로고    scopus 로고
    • Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion
    • Song J, So T, Cheng M, Tang X, Croft M, (2005) Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22(5): 621-31.
    • (2005) Immunity , vol.22 , Issue.5 , pp. 621-631
    • Song, J.1    So, T.2    Cheng, M.3    Tang, X.4    Croft, M.5
  • 21
    • 80054867338 scopus 로고    scopus 로고
    • T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy
    • Snell LM, Lin GH, McPherson AJ, Moraes TJ, Watts TH, (2011) T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol Rev 244(1): 197-217.
    • (2011) Immunol Rev , vol.244 , Issue.1 , pp. 197-217
    • Snell, L.M.1    Lin, G.H.2    McPherson, A.J.3    Moraes, T.J.4    Watts, T.H.5
  • 22
    • 0242611000 scopus 로고    scopus 로고
    • CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool
    • Hendriks J, Xiao Y, Borst J, (2003) CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 198(9): 1369-80.
    • (2003) J Exp Med , vol.198 , Issue.9 , pp. 1369-1380
    • Hendriks, J.1    Xiao, Y.2    Borst, J.3
  • 23
    • 74949120423 scopus 로고    scopus 로고
    • CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production
    • Peperzak V, Xiao Y, Veraar EA, Borst J, (2010) CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 120(1): 168-78.
    • (2010) J Clin Invest , vol.120 , Issue.1 , pp. 168-178
    • Peperzak, V.1    Xiao, Y.2    Veraar, E.A.3    Borst, J.4
  • 24
    • 65349153714 scopus 로고    scopus 로고
    • Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
    • Wang C, Lin GH, McPherson AJ, Watts TH, (2009) Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 229(1): 192-215.
    • (2009) Immunol Rev , vol.229 , Issue.1 , pp. 192-215
    • Wang, C.1    Lin, G.H.2    McPherson, A.J.3    Watts, T.H.4
  • 25
    • 77957325210 scopus 로고    scopus 로고
    • 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes
    • Sluijter BJ, van den Hout MF, Stam AG, Lougheed SM, Suhoski MM, et al. (2010) 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes. Clin Immunol 137(2): 221-33.
    • (2010) Clin Immunol , vol.137 , Issue.2 , pp. 221-233
    • Sluijter, B.J.1    van den Hout, M.F.2    Stam, A.G.3    Lougheed, S.M.4    Suhoski, M.M.5
  • 26
    • 62549160588 scopus 로고    scopus 로고
    • First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American Society of Clinical Oncology meeting
    • Molckovsky A, Siu LL, (2008) First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American Society of Clinical Oncology meeting. J. Hematol Oncol 1: 20.
    • (2008) J. Hematol Oncol , vol.1 , pp. 20
    • Molckovsky, A.1    Siu, L.L.2
  • 27
    • 79956149133 scopus 로고    scopus 로고
    • Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
    • Singh H, Figliola MJ, Dawson MJ, Huls H, Olivares S, et al. (2011) Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res 71(10): 3516-27.
    • (2011) Cancer Res , vol.71 , Issue.10 , pp. 3516-3527
    • Singh, H.1    Figliola, M.J.2    Dawson, M.J.3    Huls, H.4    Olivares, S.5
  • 28
    • 34247212403 scopus 로고    scopus 로고
    • Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
    • Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, et al. (2007) Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther 15(5): 981-8.
    • (2007) Mol Ther , vol.15 , Issue.5 , pp. 981-988
    • Suhoski, M.M.1    Golovina, T.N.2    Aqui, N.A.3    Tai, V.C.4    Varela-Rohena, A.5
  • 29
    • 79961133788 scopus 로고    scopus 로고
    • Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
    • Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, et al. (2011) Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med 9: 131.
    • (2011) J Transl Med , vol.9 , pp. 131
    • Ye, Q.1    Loisiou, M.2    Levine, B.L.3    Suhoski, M.M.4    Riley, J.L.5
  • 30
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    • Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, et al. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23(10): 2346-57.
    • (2005) J Clin Oncol , vol.23 , Issue.10 , pp. 2346-2357
    • Dudley, M.E.1    Wunderlich, J.R.2    Yang, J.C.3    Sherry, R.M.4    Topalian, S.L.5
  • 31
    • 17844381006 scopus 로고    scopus 로고
    • Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
    • Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, et al. (2005) Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother 28(3): 258-67.
    • (2005) J Immunother , vol.28 , Issue.3 , pp. 258-267
    • Huang, J.1    Khong, H.T.2    Dudley, M.E.3    El-Gamil, M.4    Li, Y.F.5
  • 32
    • 84863618564 scopus 로고    scopus 로고
    • CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells
    • Ferrer IR, Wagener ME, Song M, Ford ML, (2012) CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. PLoS One 7(7): e40559.
    • (2012) PLoS One , vol.7 , Issue.7
    • Ferrer, I.R.1    Wagener, M.E.2    Song, M.3    Ford, M.L.4
  • 33
    • 33644500140 scopus 로고    scopus 로고
    • IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival
    • Pulle G, Vidric M, Watts TH, (2006) IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J Immunol 176(5): 2739-48.
    • (2006) J Immunol , vol.176 , Issue.5 , pp. 2739-2748
    • Pulle, G.1    Vidric, M.2    Watts, T.H.3
  • 34
    • 0032374052 scopus 로고    scopus 로고
    • Role of 4-1BB in immune responses
    • Vinay DS Kwon BS, (1998) Role of 4-1BB in immune responses. Semin Immunol 10(6): 481-9.
    • (1998) Semin Immunol , vol.10 , Issue.6 , pp. 481-489
    • Vinay, D.S.1    Kwon, B.S.2
  • 35
    • 4644271443 scopus 로고    scopus 로고
    • CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
    • Sun JC, Williams MA, Bevan MJ, (2004) CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5(9): 927-33.
    • (2004) Nat Immunol , vol.5 , Issue.9 , pp. 927-933
    • Sun, J.C.1    Williams, M.A.2    Bevan, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.